Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew Quinn
Matthew Quinn
Novartis
Physical therapy
Indacaterol
Medicine
COPD
Salmeterol fluticasone
3
Papers
105
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
INSTEAD: Randomized switch trial of indacaterol and salmeterol/fluticasone combination (SFC) in moderate COPD: Symptoms results
2015
European Respiratory Journal
Andrea Rossi
Thys Van Der Molen
Ricardo del Olmo
Alberto Papi
Luis Wehbe
Matthew Quinn
Chengxing Lu
David Young
Ray Cameron
Pablo Altman
Show All
Source
Cite
Save
Citations (1)
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
2014
European Respiratory Journal
Andrea Rossi
Thys Van Der Molen
Ricardo del Olmo
Alberto Papi
Luis Wehbe
Matthew Quinn
Chengxing Lu
David Young
Ray Cameron
Enrica Bucchioni
Pablo Altman
Show All
Source
Cite
Save
Citations (104)
S103 No Loss In Efficacy Following Switch From Salmeterol/fluticasone Combination To Indacaterol Monotherapy In Patients With Moderate Copd: The Instead Study
2014
Thorax
Andrea Rossi
Thys Van Der Molen
Ricardo del Olmo
Alberto Papi
Luis Webhe
Matthew Quinn
Chengxing Lu
David Young
Ray Cameron
Enrica Bucchioni
Pablo Altman
Show All
Source
Cite
Save
Citations (0)
1